Reports for TEVA-TELMISARTAN HCTZ
Brand name
TEVA-TELMISARTAN HCTZ
Company Name
TEVA CANADA LIMITED
|
Drug Identification Number
02379252 |
Ingredients
HYDROCHLOROTHIAZIDE TELMISARTAN |
Ingredient Strength
25.0 MG 80.0 MG |
ATC Code
C09DAC09DA |
ATC Descriptor
ANGIOTENSIN II ANTAGONISTS, COMBINATIONS ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Status
MARKETED
|
Shortage reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|
TEVA-TELMISARTAN HCTZ | 100 | Resolved | 2018-11-20 | 2019-03-12 | 67246 |
TEVA-TELMISARTAN HCTZ | 30 | Resolved | 2018-11-20 | 2019-03-12 | 67243 |
TEVA-TELMISARTAN HCTZ | 100 & UD 30's | Resolved | 2020-04-03 | 2020-05-14 | 110788 |
TEVA-TELMISARTAN HCTZ | 100, PP 30's | Resolved | 2021-06-24 | 2022-01-20 | 141489 |
TEVA-TELMISARTAN HCTZ | PP30 | Actual shortage | 2024-04-11 | 2024-05-23 | 224901 |
Showing 1 to 5 of 5
Discontinuation reports
Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
---|
Showing 1 to 0 of 0